Story · Medicine & Biotech

Good news for people newly diagnosed with rare autoimmune disorder: Study finds low relapse risk

1 outlet · first reported by Medical Xpress on

People newly diagnosed with myelin oligodendrocyte glycoprotein antibody-associated disease, or MOGAD, generally had a low risk of relapse and lasting disability, according to a Kaiser Permanente study. The work is published in the journal Neurology. (Medical Xpress)

Coverage, in order

  1. Medical Xpress indie study peer-reviewed
    Good news for people newly diagnosed with rare autoimmune disorder: Study finds low relapse risk

    People newly diagnosed with myelin oligodendrocyte glycoprotein antibody-associated disease, or MOGAD, generally had a low risk of relapse and lasting disability, according to a Kaiser Permanente study. The work is published in the journal Neurology.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.